Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:duloxetine
|
| gptkbp:ATCCode |
gptkb:N06AX21
|
| gptkbp:contraindication |
severe liver impairment
uncontrolled narrow-angle glaucoma concomitant use with MAO inhibitors |
| gptkbp:drugClass |
norepinephrine reuptake inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
Baltivia
|
| gptkbp:manufacturer |
KRKA
|
| gptkbp:marketedIn |
gptkb:Europe
|
| gptkbp:pregnancyCategory |
C (varies by country)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation fatigue drowsiness dry mouth |
| gptkbp:usedFor |
gptkb:generalized_anxiety_disorder
gptkb:major_depressive_disorder fibromyalgia chronic musculoskeletal pain diabetic peripheral neuropathic pain |
| gptkbp:bfsParent |
gptkb:Polferries
|
| gptkbp:bfsLayer |
7
|